Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 153

1.

Prevalence and indicators of portal hypertension in patients with nonalcoholic fatty liver disease.

Mendes FD, Suzuki A, Sanderson SO, Lindor KD, Angulo P.

Clin Gastroenterol Hepatol. 2012 Sep;10(9):1028-33.e2. doi: 10.1016/j.cgh.2012.05.008.

2.
3.

Measurement of spleen stiffness to evaluate portal hypertension and the presence of esophageal varices in patients with HCV-related cirrhosis.

Colecchia A, Montrone L, Scaioli E, Bacchi-Reggiani ML, Colli A, Casazza G, Schiumerini R, Turco L, Di Biase AR, Mazzella G, Marzi L, Arena U, Pinzani M, Festi D.

Gastroenterology. 2012 Sep;143(3):646-54. doi: 10.1053/j.gastro.2012.05.035.

PMID:
22643348
4.

Clinical effects and complications of TIPS for portal hypertension due to cirrhosis: a single center.

Qin JP, Jiang MD, Tang W, Wu XL, Yao X, Zeng WZ, Xu H, He QW, Gu M.

World J Gastroenterol. 2013 Nov 28;19(44):8085-92. doi: 10.3748/wjg.v19.i44.8085.

5.

Clinical and laboratory predictors of esophageal varices in children and adolescents with portal hypertension syndrome.

Fagundes ED, Ferreira AR, Roquete ML, Penna FJ, Goulart EM, Figueiredo Filho PP, Bittencourt PF, Carvalho SD, Albuquerque W.

J Pediatr Gastroenterol Nutr. 2008 Feb;46(2):178-83. doi: 10.1097/MPG.0b013e318156ff07.

PMID:
18223377
6.

Features of portal hypertension are associated with major adverse events in Fontan patients: the VAST study.

Elder RW, McCabe NM, Hebson C, Veledar E, Romero R, Ford RM, Mahle WT, Kogon BE, Sahu A, Jokhadar M, McConnell ME, Book WM.

Int J Cardiol. 2013 Oct 9;168(4):3764-9. doi: 10.1016/j.ijcard.2013.06.008.

7.

Steatosis and portal hypertension.

Puoti C, Bellis L.

Eur Rev Med Pharmacol Sci. 2005 Sep-Oct;9(5):285-90.

PMID:
16231591
8.

Two findings of portal hypertension: evaluation of correlation between serum-ascites albumin gradient and esophageal varices in non-alcoholic cirrhosis.

Demirel U, Karincaoğlu M, Harputluoğlu M, Ateş M, Seçkin Y, Yildirim B, Hilmioğlu F.

Turk J Gastroenterol. 2003 Dec;14(4):219-22.

9.

Serum tests, liver stiffness and artificial neural networks for diagnosing cirrhosis and portal hypertension.

Procopet B, Cristea VM, Robic MA, Grigorescu M, Agachi PS, Metivier S, Peron JM, Selves J, Stefanescu H, Berzigotti A, Vinel JP, Bureau C.

Dig Liver Dis. 2015 May;47(5):411-6. doi: 10.1016/j.dld.2015.02.001.

PMID:
25732434
10.

von Willebrand factor as a novel noninvasive predictor of portal hypertension and esophageal varices in hepatitis B patients with cirrhosis.

Wu H, Yan S, Wang G, Cui S, Zhang C, Zhu Q.

Scand J Gastroenterol. 2015;50(9):1160-9. doi: 10.3109/00365521.2015.1037346.

PMID:
25877661
11.

[Non-invasive diagnosis of portal hypertension in cirrhosis. Application to the primary prevention of varices].

Dib N, Konate A, Oberti F, Calès P.

Gastroenterol Clin Biol. 2005 Oct;29(10):975-87. Review. French.

PMID:
16435503
12.

Clinical predictors of bleeding esophageal varices in the ED.

Goh SH, Tan WP, Lee SW.

Am J Emerg Med. 2005 Jul;23(4):531-5.

PMID:
16032626
13.

Grading of peripheral cytopenias caused by nonalcoholic cirrhotic portal hypertension and its clinical significance.

Lv Y, Han X, Gong X, Ma Q, Chang S, Wu H, Li Y, Deng J.

Cell Biochem Biophys. 2015 Mar;71(2):1141-5. doi: 10.1007/s12013-014-0321-x.

PMID:
25377543
14.

[Peptic ulcer and endoscopic signs of portal hypertension in patients with primary biliary cirrhosis].

Chesta J, Brahm J, Varas V, Macaya P, Latorre R, Smok G, Morales A.

Rev Med Chil. 1992 Jul;120(7):768-71. Spanish.

PMID:
1341817
15.

Indocyanine green retention test as a noninvasive marker of portal hypertension and esophageal varices in compensated liver cirrhosis.

Lisotti A, Azzaroli F, Buonfiglioli F, Montagnani M, Cecinato P, Turco L, Calvanese C, Simoni P, Guardigli M, Arena R, Cucchetti A, Colecchia A, Festi D, Golfieri R, Mazzella G.

Hepatology. 2014 Feb;59(2):643-50. doi: 10.1002/hep.26700.

PMID:
24038116
16.

[Idiopathic portal hypertension].

Ponomarev AA.

Vrach Delo. 1991 Aug;(8):35-9. Review. Russian. No abstract available.

PMID:
1949728
17.

Factors predicting the presence of esophageal or gastric varices in patients with advanced liver disease.

Zaman A, Hapke R, Flora K, Rosen HR, Benner K.

Am J Gastroenterol. 1999 Nov;94(11):3292-6.

PMID:
10566732
18.

[Predictive factors for portal hypertension in patients with primary sclerosing cholangitis].

Zapata-Colindres JC, Montaño-Loza A, Zepeda-Gómez S, Uscanga L.

Gastroenterol Hepatol. 2006 Jan;29(1):7-10. Spanish.

PMID:
16393623
19.

Low serum adiponectin levels are predictive of advanced hepatic fibrosis in patients with NAFLD.

Savvidou S, Hytiroglou P, Orfanou-Koumerkeridou H, Panderis A, Frantzoulis P, Goulis J.

J Clin Gastroenterol. 2009 Sep;43(8):765-72. doi: 10.1097/MCG.0b013e31819e9048.

PMID:
19525862
20.

[Etiology and complications of liver cirrhosis: data from a German centre].

Sivanathan V, Kittner JM, Sprinzl MF, Weinmann A, Koch S, Wiltink J, Nguyen-Tat M, Marquardt JU, Wörns MA, Zimmermann T, Lang H, Galle PR, Schattenberg JM.

Dtsch Med Wochenschr. 2014 Sep;139(36):1758-62. doi: 10.1055/s-0034-1387240. German.

PMID:
25157862

Supplemental Content

Support Center